Genetic modelling of muscular dystrophies

Neuropathology and Applied Neurobiology

Volumn 24, Issue 2, 1998, Pages 96-100

  Ward, C L ^a   Davies, K E ^b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROGLYCAN; DYSTROPHIN; GLYCOPROTEIN; IMMUNOSUPPRESSIVE AGENT; STEROID; UTROPHIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BECKER MUSCULAR DYSTROPHY; COMPLEX FORMATION; CONFERENCE PAPER; DUCHENNE MUSCULAR DYSTROPHY; GENE THERAPY; GENETIC MODEL; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; DYSTROPHIN; GENES, DOMINANT; GENES, RECESSIVE; GLYCOPROTEINS; HUMANS; MEMBRANE PROTEINS; MODELS, GENETIC; MUSCULAR DYSTROPHIES; UTROPHIN;

EID: 0031900797     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.1998.00005.x     Document Type: Conference Paper

References (45)

1. Ahm AH, Kunkel LM. The structural and functional diversity of dystrophin. Nature Genet 1993; 3: 283-91
2. Akaike M, Kawai H. [Gene analysis in patients with muscular dystrophy: Alpha-sarcoglycan (adhalin) gene mutations in patients with malignant limb-girdle muscular dystrophy]. Rinsho Byori 1997; 45: 136-40
3. Beckmann JS, Bushby KM. Advances in the molecular genetics of the limb-girdle type of autosomal recessive progressive muscular dystrophy. Curr Opin Neurol 1996; 9: 389-93
4. Ben Hamida M, Ben Hamida C, Zouari M, Belal S, Hentati F. Limb-girdle muscular dystrophy 2C: clinical aspects. Neuromusc Dis 1996; 6: 493-4
5. Blake DJ, Tinsley JM, Davies KE. Utrophin: a structural and functional comparison to dystrophin. Brain Pathol 1996; 6: 37-47
6. Bonnermann CG, McNally EM, Kunkel LM. Beyond dystrophin: current progress in the muscular dystrophies. Curr Opin Ped 1996; 8: 569-82
7. Bonnermann CG, Passos-Bueno MR, McNally EM et al. screening for beta-sarcoglycan gene mutations: missesnse mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E). Hum Mol Genet 1996; 5: 1953-61
8. Brown RH Jr. Dystrophin-associated proteins and the muscular dystrophies. Ann Rev Med 1997; 48: 457-66
9. Brown RH Jr. Editorial review: dystrophin-associated proteins and the muscular dystrophies: a glossary. Brain Pathol 1996; 6: 19-24
10. Campbell KP. Three muscular dystrophies, loss of cytoskeleton-extracellular matrix lineage. Cell 1995; 80: 675-9
11. Deconinck AE, Potter AC, Tinsley JM et al. Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. J Cell Biol 1997; 136: 883-94
12. Deconinck AE, Rafael JA, Skinner JA et al. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 1997; 90: 717-27
13. Dennis CL, Tinsley JM, Deconinck AE, Davies KE. Molecular and functional analysis of the utrophin promoter. Nucleic Acids Res 1996; 24: 1646-52
14. Duggan DJ, Hoffman EP. Autosomal recessive muscular dystrophy and mutations of the sarcoglycan complex. Neuromusc Dis 1996; 6: 475-82
15. England SB, Nicholson LV, Johnson MA et al. Very mild muscular dystrophy associated with the deletion of 46% dystrophin. Nature 1990; 343: 180-2
16. Grady RM, Teng H, Nichol MC, Cunningham JC, Wilkinson RS, Sanes JR. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 1997; 90: 729-38
17. Gramolini AO, Dennis CL, Tinsley JM et al. Local transcriptional control of utrophin expression at the neuromuscular synapse. J Biol Chem 1997; 272: 8117-20
18. Guicheney P, Vignier N, Helbling-Leclerc A et al. Genetics of laminin alpha 2 chain (or merosin) deficient congenital muscular dystrophy: from identification of mutations to prenatal diagnosis. Neuromusc Dis 1997; 7: 180-6
19. Hoffman EP. Clinical and histopathological features of abnormalities of the dystrophin-based membrane cytoskeleton. Brain Pathol 1996; 6: 49-61
20. Ishpekova B, Milanov I. Differential diagnosis of limb girdle syndromes. Electromyogr Clin Neurophysiol 1996; 36: 469-75
21. Jasmin BJ, Alameddine H, Lunde JA et al. Expression of utrophin and its mRNA in denervated mdx mouse muscle. FEBS Letter 1995; 374: 393-8
22. Kakulas BA. The differential diagnosis of the human dystrophinopathies and related disorders. Curr Opin Neurol 1996; 9: 380-8
23. Karpati G, Brown RH Jr The dawning of a new era in the molecular biology of the muscular dystrophies. Brain Pathol 1996; 6: 17
24. Kawajiri M, Mitsui T, Kawai H, Kobunai T, Tsuchihashi T, Saito S. Dystrophin, utrophin and beta-dystrogylcan expression in skeletal muscle from patients with Becker muscular dystrophy. J Neuropathol Exp Neurol 1996; 55: 896-903
25. Leyton QH, Gabreels FJ, Renier WO, ter Laak HJ. Congenital muscular dystrophy: a review of the literature. Clin Neurol Neurosurg 1996; 98: 267-80
26. Liu J, Lissens W, Devroey P, Liebaers I, Van Steirteghem A. Cystic fibrosis, Duchenne muscular dystrophy and preimplantation genetic diagnosis. Hum Repro Update 1996; 2: 531-9
27. Liu L, Vachon PH, Kuang W et al. Mouse adhalin: primary structure and expression during late stages of muscle differentiation in vitro. Biochem Biophys Res Comm 1997; 235: 227-35
28. Love DR, Byth BC, Tinsley JM, Blake DJ, Davies KE. Dystrophin and dystrophin-related proteins: a review of protein and RNA studies. Neuromusc Dis 1993; 3: 5-21
29. Matsumura K, Yamada H, Saito F, Sunada Y, Shimizu T. The role of dystroglycan, a novel receptor of laminin and agrin, in cell differentiation. Histol Histopathol 1997; 12: 195-203
30. Matsuo M. Duchenne/Becker muscular dystrophy: from molecular diagnosis to gene therapy. Brain Devel 1996; 18: 167-72
31. Moreira ES, Vainzof M, Marie SK, Sertie AL, Zatz M, Passos-Bueno MR. The seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q11-12. Am J Hum Genet 1997; 61: 151-9
32. Nawrotzki R, Blake DJ, Davies KE. The genetic basis of neuromuscular disorders. Trends Genet 1996; 12: 294-8
33. Nigro V, de sa Moreira E, Piluso G et al. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nature Genet 1996; 14: 195-8
34. North KN, Specht LA, Sethi RK, Shapiro F, Beggs AH. Congenital muscular dystrophy associated with merosin deficiency. J Child Neurol 1996; 11: 291-5
35. Ohlendieck K. Towards an understanding of the dy strophin-glycoprotein complex. Linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibres. Europ J Cell Biol 1996; 69: 1-10
36. Ozawa E, Yoshida M, Suzuki A, Mizuno Y, Hagiwara Y, Noguchi S. Dystrophin-associated proteins in muscular dystrophy. Hum Mol Genet 1994; 4: Spec no. 1711-6
37. Pearce M, Blake DJ, Tinsley JM et al. The utrophin and dystrophin genes share similarities in genomic structure. Human Mol Genet 1993; 2: 1765-72
38. Sunada Y, Campbell KP. Dystrophin-glycoprotein complex: molecular organization and critical roles in skeletal muscles. Curr Opin Neurol 1995; 8: 379-84
39. Slater CR. The missing link in DMD? Nature 1987; 320 (24/31): 693-694
40. Taylor J, Muntoni F, Dubowitz V, Sewry CA. The abnormal expression of utrophin in Duchenne and Becker muscular dystrophy is age related. Neuropathol Appl Neurobiol 1997; 23: 399-405
41. Tinsley JM, Davies KE. Utrophin: a potential replacement for dystrophin? Neuromusc Dis 1993; 3: 537-9
42. Tinsley JM, Blake DJ, Pearce M, Knight AE, Kendrick-Jones J, Davies KE. Dystrophin and related proteins. Curr Opin Genet Dev 1993; 3: 484-90
43. Vainzof M, Passos-Bueno MR, Canovas M et al. The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum Mol Genet 1996; 5: 1963-9
44. Winder SJ, Hemmings L, Maciver SK et al. Utrophin actin binding domain: analysis of actin binding and cellular targeting. J Cell Sci 1995; 108 (Pt 1): 63-71
45. Worton R. Muscular dystrophies, diseases of the dystrophin-glycoprotein complex. Science 1995; 270: 755-6